Normotemp

Quick links to important sections

Normotemp

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Normotemp

Property Description
Active Ingredient Acetaminophen (Paracetamol)
Form Tablet, Capsule, Oral Suspension, Suppository
Pharmacological Class Analgesic and Antipyretic
Common Use Relief of pain and fever
Origin Synthetic compound

What is Normotemp and How is it Classified?

Normotemp is a specific brand name medication. Its active ingredient is Acetaminophen, known internationally as Paracetamol (N-acetyl-p-aminophenol). Pharmacologically, it is classified as both an Analgesic (a pain reliever) and an Antipyretic (a fever reducer) and belongs to the para-aminophenol derivative class. This dual function confirms the medication’s primary purpose: addressing both discomfort and elevated body temperature. It is recognized as an essential agent for managing common symptoms.

Composition and Available Forms of Normotemp

Normotemp is a monocomponent drug, meaning its core is the Acetaminophen molecule combined with necessary pharmaceutical excipients. The product is manufactured in several high-level dosage forms, including the solid tablet and capsule, the liquid oral suspension often used for pediatric patients, and the suppository for rectal administration. This diversity of forms facilitates both the oral and rectal routes of administration, offering flexibility when the oral route is compromised.

General Purpose and Unique Pharmacological Profile

The general purpose of Normotemp is the management of mild to moderate pain and the controlled reduction of fever. It achieves this by acting centrally to increase the body’s pain threshold and influencing the thermal regulation center in the brain. Its pharmacological action is distinct from that of Nonsteroidal Anti-inflammatory Drugs (NSAIDs); unlike NSAIDs, Acetaminophen does not possess significant peripheral anti-inflammatory effects. This unique, focused action makes the medicine suitable for patients seeking effective relief primarily through central nervous system pathways.

Regulatory References

  1. NIH Drug Information

What side effects are possible with Normotemp?

Possible Side Effects and Safety Information

The safety profile for Normotemp (Acetaminophen/Paracetamol) is defined by regulatory authorities through specific classifications of adverse reactions and essential use constraints. The majority of documented side effects, when the medication is used within official guidelines, fall into the Rare (occurring in fewer than 1 in 1,000 users) or Very Rare categories.

Official Adverse Reaction Groupings

Adverse reactions are officially grouped by the System-Organ Class (SOC) they affect, which includes Hepato-biliary disorders, Skin and subcutaneous tissue disorders, Immune system disorders, and Blood and lymphatic system disorders. General gastrointestinal effects like nausea or vomiting are also reported.

Serious Adverse Reactions

The most significant safety constraint documented in official labeling is the potential for Severe Hepatic Injury and Acute Liver Failure, a risk most closely associated with exceeding the maximum recommended dose. Other serious, though infrequent, adverse reactions include documented Serious Skin Reactions (SSR), such as Stevens-Johnson Syndrome (SJS), and Anaphylactic Shock.

Safety Constraints and Special Populations

Regulatory documents specify that Normotemp is contraindicated in individuals with known hypersensitivity to the active substance and in those with severe hepatic impairment or active liver disease. Caution is also noted for patients with severe renal impairment and those with conditions that increase the risk of liver toxicity, such as chronic alcoholism. Furthermore, prolonged regular daily use may enhance the effect of oral anticoagulants (e.g., warfarin), increasing the risk of bleeding.

Overdose and Emergency Response

Overdose of Normotemp (Acetaminophen/Paracetamol) is a serious, potentially fatal event driven by the risk of delayed-onset hepatotoxicity leading to fulminant hepatic failure. Regulatory authorities mandate that immediate emergency medical assessment is required for any suspected overdose, even if initial clinical signs are mild or absent.

Documented Clinical Presentation

Early manifestations, typically seen within 24 hours of overexposure, are often non-specific, including nausea, vomiting, pallor, anorexia, and excessive sweating. Severe, late-stage signs reflect progressive liver damage and may include jaundice, abdominal pain, and the development of hepatic encephalopathy. Documented laboratory abnormalities include elevated hepatic transaminases and prolonged prothrombin time. Overdose severity is noted to be potentially increased in patient populations with pre-existing hepatic impairment or chronic malnourishment.

Regulator-Mandated Emergency Response

Medical help must be sought immediately; the overdose profile is defined by the need for rapid intervention and continuous hospital observation due to the risk of delayed severe outcomes. Acetylcysteine is documented as the specific antidote for Acetaminophen overdose and must be administered promptly in a clinical setting to mitigate the risk of severe liver damage. Supportive and symptomatic treatment is also required.

Therapeutic Uses of Normotemp

What Normotemp Treats: Main Uses and Benefits

Normotemp is commonly used in the symptomatic management of pain and fever, applicable in a wide range of everyday scenarios and across several key therapeutic domains.

The medication is fundamentally applied for the symptomatic relief of mild to moderate acute pain. This includes addressing common pain manifestations such as tension headaches, backaches, toothaches, muscle aches (myalgia), and the discomfort associated with recurrent conditions like menstrual cramps. As an established antipyretic, it is also relevant for managing elevated body temperature (fever) associated with acute common illnesses like colds and influenza. The medication is applied when appropriate for easing distressing symptoms during symptomatic phases.

Normotemp provides support that helps ease the overall symptom burden, assisting patients in coping more steadily with disruptive episodes.

This symptomatic support is relevant across multiple patient groups, including adults and pediatric patients. It is often applied in clinical settings marked by the acute onset of symptoms, such as post-immunization soreness or routine dental discomfort, contributing to easing distress in situations where symptoms interfere with daily functioning.


Quick Fact: Applied to address symptoms related to Systemic Imbalance and Physical Discomfort


Eligibility and Restrictions for Use

Who Can and Cannot Use Normotemp? — Official Eligibility Information

This medicine's eligibility is strictly defined by regulatory documents, primarily excluding specific populations based on hypersensitivity, age, and pre-existing conditions.


Contraindications and Exclusions

Classification Exclusion/Restriction Criterion Affected Population/Status
Contraindicated Hypersensitivity Patients with known allergy to the active substance (Paracetamol) or any excipients.
Not Recommended Age Restriction Children under the age of 10 years.

Special Considerations and Restrictions

Use is allowed for adults, the elderly, and children aged 10 to 15 years. However, official labeling mandates special care and caution for certain groups due to increased risk or altered metabolism:

  • Severe Organ Impairment: Care is advised in patients with severe renal impairment or severe hepatic impairment (liver disease).
  • Glutathione Deficiency: The hazard of overdose is greater in patients with non-cirrhotic alcoholic liver disease, malnutrition, or other conditions leading to glutathione depletion (e.g., chronic alcoholism). This requires careful assessment and monitoring.
  • Duration: Regulatory guidance states the medicine should not be taken for more than 3 days without consulting a health professional, which serves as an operational eligibility constraint for prolonged use.

Regulatory documents primarily define eligibility by prohibiting use for hypersensitivity and excluding the youngest pediatric group while imposing strict caution for individuals with severe liver or kidney issues.

What should I know about interactions with other medicines?

Co-administration of Normotemp with any other medicinal product containing the active ingredient, acetaminophen (paracetamol), is formally contraindicated. This restriction is documented to prevent patients from exceeding the maximum recommended daily dose, thereby mitigating the severe risk of hepatic injury.

Normotemp is also contraindicated for use in patients with severe hepatic impairment or severe active liver disease. This population-specific restriction is based on the increased risk of toxicity due to the impaired clearance of the medication, which can heighten the risk associated with all interacting substances.

A clinically significant pharmacodynamic interaction is noted with Vitamin K antagonists, such as warfarin. Regulatory documents state that chronic, high-dose use of Normotemp has been shown to result in an increase in the International Normalized Ratio (INR), which indicates a potentiation of the anticoagulant effect.

Regarding metabolism, substances that induce the hepatic enzyme CYP2E1 are documented as potentially altering the drug’s metabolism and increasing its hepatotoxic potential. Furthermore, chronic, excessive consumption of alcohol (defined as three or more drinks per day) is officially associated with severe liver damage when combined with this medication. No mandatory timing-based separation rules for administration are explicitly detailed in primary regulatory labeling.

Mechanism of Action

Normotemp is a small molecule that functions as a highly selective competitive antagonist at the prostaglandin E2 receptor subtype 4 ( EP4). This interaction specifically prevents the binding of endogenous PGE2 to the receptor, thereby modulating EP4-mediated signaling cascades, particularly in immune and endothelial cells.

The molecular action of Normotemp involves the inhibition of Gs-protein coupling, which blocks the downstream catalytic conversion of ATP into the second messenger, cyclic adenosine monophosphate ( cAMP). Reduced cAMP levels diminish the activation of Protein Kinase A ( PKA). Consequently, this disrupts the PKA-dependent phosphorylation and activation of transcription factors within the NF-kappa B and MAPK pathways. The net result is an altered, reduced profile of proinflammatory cytokine release, including key mediators such as IL-6 and TNF-alpha, thereby providing systemic physiological modulation of cellular responses.

Dosage and Administration Information

Normotemp is administered through three primary pathways: oral (tablets, capsules, liquids), rectal (suppositories), and by intravenous (IV) infusion in specialized care settings. The general principle of use is adherence to strict quantitative limits and defined time intervals, ensuring that the total daily consumption from all sources remains within established specifications. The medicine is designated for short-term use, and the timing of intake is flexible, as it may be taken with or without food.

Administration Parameter Instruction
Standard Dosing (Adults ≥ 50 kg) 1,000 mg every 6 hours or 650 mg every 4 hours
Max Daily Limit 4,000 mg (4 grams) cumulative from all routes
Minimum Interval 4 hours between successive doses

Standard adult dosing is structured to respect the maximum ceiling. For all forms, a minimum of four hours must pass between sequential doses. For specialized administration, specific handling protocols are mandated: the IV solution is administered as a 15-minute infusion, and oral liquid suspensions require the use of a calibrated dosing device to ensure volumetric precision. Dosage is not universally fixed; use for children and adolescents weighing less than 50 kg is determined by body weight (mg/kg). Furthermore, guidelines state that the dosing interval must be prolonged for individuals with severe hepatic or renal impairment, a modification that accounts for altered clearance. If a dose is missed, it should be taken only if the next dose is not due for the full minimum required interval.

Recent Clinical Evidence

Research evidence / Overview of studies for Normotemp

Evidence for Use in Acute Pain Relief

The evidence base for acute pain has been thoroughly explored through extensive short-term Randomized Controlled Trials (RCTs) and Systematic Reviews. Research explored patient-reported outcomes describing perceived discomfort stemming from issues like headaches or muscle aches. These studies monitored outcomes related to physical discomfort using standardized measurement scales. Post-surgical trials described patterns related to the monitored use of supplemental pain medications when compared to control groups.

Evidence for Use in Fever Reduction (Antipyresis)

Normotemp was evaluated in research exploring outcomes related to systemic or functional imbalance. The primary evidence is derived from RCTs that specifically examined temporary physiological imbalance in both adult and pediatric patients. These studies monitored how the body’s thermal status evolved in the observed populations, and research examined measurements of change over defined time intervals. Follow-up durations were typically limited to the immediate hours following administration.

Research Structure for Chronic Pain Conditions

For certain conditions characterized by functional limitations, such as Osteoarthritis, Normotemp was evaluated in Systematic Reviews and Meta-Analyses of RCTs. Research examined outcomes related to daily functioning or activity level over periods of several weeks or months. Findings were mixed; some studies reported patterns related to the measurement of changes in pain scores, while other evidence indicates that results were modest or that findings were mixed when compared to control groups.

What Remains Uncertain and Research Gaps

Long-term effects are not fully established for both acute and chronic use scenarios, as follow-up durations were limited in many primary efficacy trials. Data for certain groups requiring long-term treatment remains insufficient. The results apply only to the populations studied in the RCTs, and comparative evidence is lacking in many areas, meaning definitive conclusions about long-term maintenance or complex subgroup findings are uncertain.

Key Studies & References

  1. NIH/MedlinePlus: Acetaminophen (Oral Route, Rectal Route) Drug Information
  2. Systematic review of the clinical evidence of paracetamol in pediatrics (Journal of Clinical Medicine)
  3. Health Canada Advisory: Acetaminophen

Frequently Asked Questions (FAQ)

Common questions about Normotemp (FAQ)

Q: What is the main difference between Normotemp and acetaminophen?

Normotemp is a specific brand name medication. The substance that makes the medicine work, called the active ingredient, is acetaminophen (which is also known as Paracetamol). Therefore, Normotemp is one of many different products that contain the same active ingredient.


Q: Is Normotemp the same kind of medicine as aspirin or ibuprofen?

Official information describes Normotemp's active ingredient as a type of analgesic (pain reliever) and antipyretic (fever reducer). It is important to know that its action is distinct from that of drugs like aspirin or ibuprofen, which are classified as Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Unlike NSAIDs, the active ingredient in Normotemp does not possess significant peripheral anti-inflammatory effects.


Q: Does Normotemp need a prescription from a doctor?

The active ingredient in Normotemp, acetaminophen, is found in hundreds of products sold worldwide. It is available in forms designated for both Over-The-Counter (OTC) use and those requiring a prescription from a healthcare professional.


Q: How long does Normotemp typically take to start working?

Clinical information suggests that for the most common forms of administration, like oral tablets or capsules, the analgesic (pain-relieving) effect is often observed to begin around one hour after consumption. The onset time may vary depending on the specific product formulation.


Q: How quickly does the effect of Normotemp wear off?

The duration of the pain-relieving and fever-reducing effects is generally described in product information as being between 4 to 6 hours. The minimum time interval between doses is established in regulatory documents to mitigate the risk of the total daily dose from being exceeded.


Q: What should I do if I think I missed a dose of Normotemp?

Regulatory guidelines specify that a missed dose is to be taken only if the full minimum required interval will pass before the next scheduled dose. This condition is established in regulatory documents to mitigate the risk of exceeding the total maximum daily amount.


Q: Can Normotemp be taken with vitamins or daily supplements?

Official guidance emphasizes the importance of informing a healthcare professional of all drugs, vitamins, and supplements being used before starting the medication. This practice is recommended because some supplements, particularly certain herbal products, may affect the drug's metabolism or alter the risk of liver toxicity.


Q: Is it possible to develop a dependency on Normotemp?

The active ingredient in Normotemp is not classified as an opioid and is not regulated as a substance associated with physical dependence in the same way as controlled substances. However, some clinical reports have discussed the possibility of psychological dependence or misuse associated with common pain relievers.


Q: Are there any long-term effects associated with Normotemp use?

Research summaries note that the long-term effects are not fully established for acute and chronic use scenarios because many primary efficacy trials have had limited follow-up durations. However, chronic, long-term use is noted in regulatory documents to be associated with an increased risk of hepatic (liver) injury and a potentiation of oral anticoagulant effects.


Q: Do food or certain drinks affect how Normotemp works?

Official instructions state that the medicine may be taken with or without food. However, some clinical resources indicate that consuming the drug with food may delay and slightly decrease the overall absorption of the active ingredient into the body.


Q: What if I experience mild dizziness after using Normotemp?

Dizziness is listed in regulatory data as a possible side effect, though it is not a common occurrence. Official guidance emphasizes that if any symptoms or unexpected effects worsen, regulatory advice is to discontinue use and seek professional medical assessment.


Q: Are there different strengths or forms of Normotemp available?

Yes, the active ingredient is available in multiple pharmaceutical forms, including tablets, capsules, liquid solutions, suppositories, and IV solutions. These forms also come in several different strengths, such as 325 mg, 500 mg, and 650 mg for oral products.


Q: Can Normotemp be used by individuals with kidney issues?

Regulatory guidelines indicate that standard doses are generally considered safe for use in patients with Chronic Kidney Disease (CKD). However, the regulatory guidelines indicate that the dosing interval is typically prolonged for patients with severe renal impairment to account for altered clearance.


Q: Can Normotemp be crushed or split if it is a tablet?

Regulatory information for certain products, such as extended-release tablets, often explicitly states that they should not be crushed, chewed, or split, as this action can release the full dose too quickly. Official guidance states that altering the form of immediate-release tablets should be based on the direction of a healthcare professional.


Q: How long can Normotemp be used before needing a medical review?

Official Over-The-Counter (OTC) regulatory guidance states that the medicine should not be taken for more than 3 days for fever or 10 days for pain (5 days for children) without consulting a health professional. These limits are in place to ensure that the underlying condition causing the symptoms is properly diagnosed and managed.


Q: Is it possible to take Normotemp with multiple other daily medications?

Regulatory guidance highlights the importance of informing a healthcare provider of all other medications (prescription and OTC) being used. The drug is known to interact with substances such as other products containing the same active ingredient, Vitamin K antagonists, and certain enzyme-inducing agents.


Q: Does Normotemp affect the ability to drive or operate machinery?

Although it is not a primary side effect, regulatory adverse event lists mention potential symptoms such as dizziness or somnolence (drowsiness). If these symptoms are experienced, official guidance mentions the need for caution with activities requiring mental alertness, such as driving or operating machinery.


Q: Are there any common interactions with over-the-counter cold medicines?

Yes, a critical regulatory warning is that many over-the-counter cold, cough, and flu medicines also contain acetaminophen. It is formally contraindicated (prohibited) to combine these products, as this practice increases the risk of exceeding the maximum daily dose and potentially causing hepatic (liver) injury.


Q: Does Normotemp cause weight changes?

Official adverse event lists mention weight gain as a potential side effect, though it is not listed as a common effect, and the exact incidence is generally not known for the single-ingredient product.


Q: Is Normotemp safe for a person who has a history of heart problems?

Standard (non-sodium containing) formulations of the medicine are generally regarded as compatible with use in individuals with a history of heart problems. However, scientific literature suggests a potential association between the regular use of certain sodium-containing effervescent forms of the active ingredient and increased risks for cardiovascular outcomes.


Q: Can Normotemp cause sleepiness or insomnia?

Regulatory adverse event data indicates that both somnolence (drowsiness) and insomnia are listed as potential side effects, although the reported frequency for the single-ingredient product is generally low or unknown.


Q: Why does the packaging for Normotemp mention alcohol use?

The packaging mentions alcohol because chronic, excessive consumption (defined as three or more drinks per day) is officially associated with a heightened risk of developing hepatic (liver) injury and failure when the medicine is used.


Q: What is the evidence that Normotemp works for its main use?

The evidence base for the medicine’s main uses—relief of acute pain and fever reduction—is supported by extensive short-term Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies examine patient-reported discomfort and changes in the body’s thermal status.


Q: Is Normotemp safe for older adults (senior citizens)?

Official labeling indicates that the medicine may be used by the elderly population. However, regulatory documents advise special care and caution for individuals in this group, particularly if they have underlying conditions like severe renal impairment, where the dosing interval is typically modified.


Q: Is Normotemp considered a generic drug, or is it only available as a brand?

Normotemp is a specific brand name. The active ingredient, Acetaminophen (Paracetamol), is also widely available as an identical generic medication, which is often sold under its chemical name.


Q: What is Normotemp meant to do inside the body?

The primary purpose of the medicine is to manage discomfort and reduce elevated body temperature (fever). It achieves this by acting primarily on the central nervous system, specifically by influencing the body’s pain threshold and the temperature regulation center in the brain.


Q: Are there any studies looking at Normotemp's use in pregnant individuals?

Official sources confirm that the FDA continues to monitor and evaluate the use of the active ingredient during pregnancy. While the FDA has not found clear evidence that appropriate use causes adverse outcomes, some observational studies have explored an association between chronic use and potential neurological conditions in children.

How should Normotemp be stored and disposed of?

How to Store and Dispose of Normotemp?

Normotemp (Acetaminophen/Paracetamol) must be stored according to official regulatory guidelines to maintain its stability and effectiveness.

Storage Requirements

The product must be stored at Controlled Room Temperature, typically 20 C to 25 C. The medicine must be protected from excess moisture, direct light, and excessive heat, and should not be stored in the bathroom. Liquid and suppository forms must be kept from freezing.

Keep the medicine in its original container, ensuring the cap is tightly closed.

Child Safety and Disposal

All forms of Normotemp must be stored out of the sight and reach of children and pets. The use of safety caps should be secured immediately after use.

For disposal, the regulatory preference is to use a drug take-back program or a regulated collection point. If not available, follow the official method of mixing the product with an unpalatable substance, sealing it in a bag, and discarding it in household trash. Do not flush the medicine down the toilet or discard it in wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Normotemp found in:

A-Z Index: